This trial will study the safety and tolerability of VH3810109 given by injection, either under the skin or into a vein. Participants will be given a single dose of the drug and will be monitored for side effects for 24 weeks.
12 Primary · 36 Secondary · Reporting Duration: Day 1, 2 and 7
Awards & Highlights
3 Treatment Groups
VH3810109 + rHuPH20
1 of 3
Part 1: VH3810109 + rHuPH20
1 of 3
Part 2: VH3810109
1 of 3
24 Total Participants · 3 Treatment Groups
Primary Treatment: VH3810109 · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 18 - 65 · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this research focusing on participants aged 35 or older?
"To be eligible for this study, patients must fall within the age bracket of 18 to 65. Fortunately, there are many additional trials available for minors and senior citizens; 108 studies exist for those under 18 years old and 353 options for people over 65." - Anonymous Online Contributor
Might I be eligible to participate in this medical experiment?
"8 individuals living with HIV, aged between 18 and 65, are invited to participate in this research. To be suitable for inclusion, they must meet certain criteria regarding their health as determined by medical history assessment, physical examination tests and laboratory checks; plus having no pre-existing conditions listed in the study's protocol." - Anonymous Online Contributor
What potential adverse reactions may arise from utilization of VH3810109?
"Due to a paucity of data, VH3810109 scored 1 on our safety scale. As it is currently in Phase 1 trials, the efficacy and safety are only minimally supported by evidence." - Anonymous Online Contributor
Are there any open roles for participants within this exploration?
"Affirmative. According to information posted on clinicaltrials.gov, this research endeavour is currently seeking enrollees. The experiment was initially listed on February 23rd 2022 and underwent a recent edit on September 19th 2022. A total of 8 participants need to be recruited from 1 study site.." - Anonymous Online Contributor
How many participants are enrolled in this investigation?
"Confirmed. The clinicaltrials.gov registry reveals that recruitment for this study, which was first announced on February 23rd 2022, is underway. A total of 8 participants are being sought from one medical facility." - Anonymous Online Contributor